Geode Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-98,647
| Closed | -$5.21M | – | 4330 |
|
|
2020
Q3 | $5.21M | Buy |
98,647
+3,887
| +4% | +$240K | ﹤0.01% | 2376 |
|
|
2020
Q2 | $5.81M | Buy |
94,760
+617
| +0.7% | +$35.7K | ﹤0.01% | 2246 |
|
|
2020
Q1 | $5.33M | Buy |
94,143
+2,217
| +2% | +$126K | ﹤0.01% | 2108 |
|
|
2019
Q4 | $5.23M | Sell |
91,926
-3,914
| -4% | -$207K | ﹤0.01% | 2420 |
|
|
2019
Q3 | $5.13M | Sell |
95,840
-3,212
| -3% | -$187K | ﹤0.01% | 2367 |
|
|
2019
Q2 | $5.91M | Buy |
99,052
+16,946
| +21% | +$1.07M | ﹤0.01% | 2288 |
|
|
2019
Q1 | $5.12M | Buy |
82,106
+14,089
| +21% | +$932K | ﹤0.01% | 2325 |
|
|
2018
Q4 | $4.12M | Buy |
68,017
+4,056
| +6% | +$242K | ﹤0.01% | 2332 |
|
|
2018
Q3 | $3.74M | Sell |
63,961
-589
| -0.9% | -$30.1K | ﹤0.01% | 2546 |
|
|
2018
Q2 | $2.9M | Buy |
64,550
+5,759
| +10% | +$248K | ﹤0.01% | 2641 |
|
|
2018
Q1 | $2.61M | Sell |
58,791
-172
| -0.3% | -$7.22K | ﹤0.01% | 2622 |
|
|
2017
Q4 | $2.55M | Buy |
58,963
+5,160
| +10% | +$232K | ﹤0.01% | 2615 |
|
|
2017
Q3 | $2.5M | Sell |
53,803
-3,500
| -6% | -$168K | ﹤0.01% | 2619 |
|
|
2017
Q2 | $2.84M | Sell |
57,303
-8,756
| -13% | -$459K | ﹤0.01% | 2526 |
|
|
2017
Q1 | $3.62M | Buy |
66,059
+9,462
| +17% | +$501K | ﹤0.01% | 2303 |
|
|
2016
Q4 | $3.15M | Buy |
56,597
+7,967
| +16% | +$383K | ﹤0.01% | 2358 |
|
|
2016
Q3 | $2.22M | Buy |
48,630
+7,132
| +17% | +$286K | ﹤0.01% | 2500 |
|
|
2016
Q2 | $1.66M | Buy |
41,498
+459
| +1% | +$16.8K | ﹤0.01% | 2606 |
|
|
2016
Q1 | $1.43K | Buy |
41,039
+6,308
| +18% | +$232K | ﹤0.01% | 2678 |
|
|
2015
Q4 | $1.49M | Sell |
34,731
-1,709
| -5% | -$85.6K | ﹤0.01% | 2655 |
|
|
2015
Q3 | $1.59M | Buy |
36,440
+1,371
| +4% | +$74K | ﹤0.01% | 2588 |
|
|
2015
Q2 | $1.81M | Buy |
35,069
+1,438
| +4% | +$61.3K | ﹤0.01% | 2560 |
|
|
2015
Q1 | $1.32M | Buy |
33,631
+3,304
| +11% | +$129K | ﹤0.01% | 2707 |
|
|
2014
Q4 | $1.17M | Buy |
30,327
+7,036
| +30% | +$268K | ﹤0.01% | 2749 |
|
|
2014
Q3 | $822K | Buy |
23,291
+2,161
| +10% | +$63.5K | ﹤0.01% | 2905 |
|
|
2014
Q2 | $569K | Buy |
21,130
+6,011
| +40% | +$157K | ﹤0.01% | 3104 |
|
|
2014
Q1 | $391K | Sell |
15,119
-505
| -3% | -$12.1K | ﹤0.01% | 3252 |
|
|
2013
Q4 | $338K | Buy |
15,624
+32
| +0.2% | +$655 | ﹤0.01% | 3244 |
|
|
2013
Q3 | $304K | Sell |
15,592
-8
| -0.1% | -$142 | ﹤0.01% | 3155 |
|
|
2013
Q2 | $243K | Buy |
+15,600
| New | +$251K | ﹤0.01% | 3167 |
|
Other funds holding BSTC
Geode Capital Management's BSTC Position: Q4 2020 in Review
Geode Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 98,647 shares — an estimated $5.21M sold.
Geode Capital Management first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $5.91M in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Geode Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Geode Capital Management sold 98,647 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $5.21M.
- Geode Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Geode Capital Management's BioSpecifics Technologies Corp. position peaked at $5.91M in Q2 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.